Skip to main content
Caplight Logo









Damona Pharmaceuticals

Damona Pharmaceuticals

Private
TorontoHealthcare & Life Scienceshttps://www.damonapharma.com/

Last Round

Seed

Sep 26, 2022

Total Funding Raised

$5.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Damona Pharmaceuticals is a biopharmaceutical company that develops small molecule therapeutics designed to restore cognitive function across neurological and psychiatric disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalsmall-molecule therapeuticscognitive impairmentdrug discoveryprecision medicineclinical-stage biotechneurodegenerative diseaseCNS disordersclinical trialsdrug developmentbiotech startupneuroscience researchtherapeutic pipelinepharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Damona Pharmaceuticals Comparables

Compare Damona Pharmaceuticals with similar companies based on industry and business-model similarity.

Damona Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Gabather AB
84%
Avenue Therapeutics Inc
78%
Praxis Precision Medicines, Inc.
77%

Damona Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 26, 2022

Key People

Founding team and executive leadership

John Reilly

Chief Executive Officer

Executive Team

Damona Pharmaceuticals Investors

Notable investors and investment history

Damona Pharmaceuticals investors
InvestorRounds
Ontario Brain InstituteSeed
Noetic FundSeed
Angelini VenturesSeed
Lumira VenturesSeed
TIAPSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 61% MoM, reaching 2.3K.

Damona Pharmaceuticals Filings

Explore SEC and related filing metadata, where available.

Damona Pharmaceuticals filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Damona Pharmaceuticals's valuation, stock price, and market status.

Is Damona Pharmaceuticals a public or private company?

Damona Pharmaceuticals is a private company.

What is the current stock price of Damona Pharmaceuticals?

Damona Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.

How much is Damona Pharmaceuticals worth (valuation)?

Valuation information for Damona Pharmaceuticals is not publicly available.

Can I buy Damona Pharmaceuticals stock?

Damona Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Damona Pharmaceuticals's last funding round?

Damona Pharmaceuticals's most recent funding round was Seed on September 26, 2022.

Who are the main investors in Damona Pharmaceuticals?

Key investors in Damona Pharmaceuticals include Noetic Fund.

Will Damona Pharmaceuticals IPO soon?

No public IPO plans have been announced for Damona Pharmaceuticals.

How can I track Damona Pharmaceuticals secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Damona Pharmaceuticals's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersToronto
Employee Range2
Year Founded2019
Last FundingSep 26, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?